-->
-->
-->
Global Biologics Market Analysis, 2020 market research report depicts a deep-dive market analysis of statistics of Global Biologics market which consists of regional and country-wise market size, forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.
The growth of the Biologics market is associated with several factors such as the surge in healthcare spending, hike in the sedentary lifestyles of individuals, a rising number of chronic diseases patients. According to the World Health Organization (WHO), by 2020 chronic diseases would account for 75% of deaths globally. Cancer, autoimmune diseases, and diabetes contribute above 60% of the overall Biologics market. The astounding impact of COVID-19 has been leading to numerous research initiatives in biologics so as to find a suitable cure. This global pandemic is set to boost the global investments in biologics in the forthcoming years.
Other factors for driving the demand for the biologics in the market are galvanized usage of monoclonal antibodies for the treatment of disease and innovation and advancement in the healthcare and biotechnology sectors. Moreover, regulatory approval from the governments in different countries is also contributing to the growth of the Biologics market.
According to MarkNtel Advisors’ research report titled “Global Biologics Market Analysis, 2020”, the Global Biologics market is anticipated to grow at a CAGR of around 10% during 2020-25. The development of biosimilars and lack of oral absorption and operational act as a market hindrance for the growth of the Biologics market.
North America Witnessing a Steady Rise in Growth of Biologics Market
The North America region market is driven due to the spurring approvals in the U.S comprising larger patent protection in comparison to approvals in the European region. Therefore, the North America region held a major market share in 2019. The region witnessed the largest corona fatalities in comparison to other regions across the globe. This grim societal scenario has been pushing the pharma giants to invest in biologics in cohesion with the governments. Other factors attributed to the growth in the region are growing diabetes patients, surging aging population, and availability of a large number of research centers. Middle East region shows considerable growth due to the less stringent norms with regard to biologics by the government as stated in the MarkNtel Advisors’ research report “Global Biologics Market Analysis, 2020”.
Vaccines Segment Showed an Amplified Demand
The vaccines segment in 2019 accounted for a considerable market share owing to the increasing government and non-government initiatives for vaccine R&D activities and the prevention of various infectious diseases. Moreover, the development of bivalent and pentavalent vaccines that can prevent an individual from more than one disease has also been developed across the world fuelling the growth of the segment.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Biologics market include Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc., Bristol-Myers Squibb, Novartis, Pfizer, Sanofi, etc.
Key Questions Answered in the Market Research Report
Market Outlook, Segmentation and Statistics
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Biologics Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million,
Q. What would be the growth rate or CAGR of Global Biologics Market during 2020-25?
A. The growth rate of Global Biologics Market during 2020-25 is forecast to be around 10%.
Q. Who are the key competitors or players operating in Global Biologics Market?
A. Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZenca Plc., Bristol-Myers Squibb, Novartis, Pfizer, Sanofi are few of the leading players in the Global Biologics Market.
Q. Which products segment would emerge as an opportunity area for players in Global Biologics Market?
A. Vaccines segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which distribution channel would emerge as an opportunity area for players in Global Biologics Market?
A. The retail pharmacies segment grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Biologics Market.
